Related references
Note: Only part of the references are listed.Emerging Strategies for Treating Brain Metastases from Breast Cancer
David P. Kodack et al.
CANCER CELL (2015)
Cell cycle control as a promising target in melanoma
Belinda Lee et al.
CURRENT OPINION IN ONCOLOGY (2015)
Quantitative HER2 and p95HER2 levels in primary breast cancers and matched brain metastases
Renata Duchnowska et al.
NEURO-ONCOLOGY (2015)
Heregulin-HER3-HER2 signaling promotes matrix metalloproteinase-dependent blood-brain-barrier transendothelial migration of human breast cancer cell lines
Majid Momeny et al.
ONCOTARGET (2015)
Nuclear HER4 mediates acquired resistance to trastuzumab and is associated with poor outcome in HER2 positive breast cancer
Siti Norasikin Mohd Nafi et al.
Oncotarget (2015)
Incidence of central nervous system metastases in patients with HER2-positive metastatic breast cancer treated with pertuzumab, trastuzumab, and docetaxel: results from the randomized phase III study CLEOPATRA
S. M. Swain et al.
ANNALS OF ONCOLOGY (2014)
Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
Antonio C. Wolff et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2014)
Serpins Promote Cancer Cell Survival and Vascular Co-Option in Brain Metastasis
Manuel Valiente et al.
CELL (2014)
Therapeutic Targeting of Cancers with Loss of PTEN Function
Lloye M. Dillon et al.
CURRENT DRUG TARGETS (2014)
Recommendations on Disease Management for Patients With Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases: American Society of Clinical Oncology Clinical Practice Guideline
Naren Ramakrishna et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Functional Imaging of Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer Using Cu-64-DOTA-Trastuzumab PET
Joanne E. Mortimer et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
Metastatic progression of breast cancer: insights from 50 years of autopsies
Margaret C. Cummings et al.
JOURNAL OF PATHOLOGY (2014)
DNA Double-Strand Break Repair Genes and Oxidative Damage in Brain Metastasis of Breast Cancer
Stephan Woditschka et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
erbB3 Is an Active Tyrosine Kinase Capable of Homo- and Heterointeractions
Mara P. Steinkamp et al.
MOLECULAR AND CELLULAR BIOLOGY (2014)
Convergent and Divergent Cellular Responses by ErbB4 Isoforms in Mammary Epithelial Cells
Vikram B. Wali et al.
MOLECULAR CANCER RESEARCH (2014)
Analysis of tumour-and stroma-supplied proteolytic networks reveals a brain-metastasis-promoting role for cathepsin S
Lisa Sevenich et al.
NATURE CELL BIOLOGY (2014)
The maintenance of chromosome structure: positioning and functioning of SMC complexes
Kristian Jeppsson et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
HER4 and its cytoplasmic isoforms are associated with progression-free survival of malignant melanoma
Trine O. Nielsen et al.
MELANOMA RESEARCH (2014)
Human breast cancer metastases to the brain display GABAergic properties in the neural niche
Josh Neman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
The localization of HER4 intracellular domain and expression of its alternately-spliced isoforms have prognostic significance in ER+HER2-breast cancer
Saori Fujiwara et al.
ONCOTARGET (2014)
ERBB3 is required for metastasis formation of melanoma cells
S. Tiwary et al.
ONCOGENESIS (2014)
Targeting MET Amplification as a New Oncogenic Driver
Hisato Kawakami et al.
CANCERS (2014)
Comparative sequencing analysis reveals high genomic concordance between matched primary and metastatic colorectal cancer lesions
A. Rose Brannon et al.
GENOME BIOLOGY (2014)
Frequent Genetic Alterations in EGFR- and HER2-Driven Pathways in Breast Cancer Brain Metastases
Ina Hohensee et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
Pazopanib Inhibits the Activation of PDGFRβ-Expressing Astrocytes in the Brain Metastatic Microenvironment of Breast Cancer Cells
Brunilde Gril et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
The prognostic value of Her4 receptor isoform expression in triple-negative and Her2 positive breast cancer patients
Anna Machleidt et al.
BMC CANCER (2013)
Estrogen receptor α is the major driving factor for growth in tamoxifen-resistant breast cancer and supported by HER/ERK signaling
Susan Thrane et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
Dual Targeting of EGFR and HER3 with MEHD7945A Overcomes Acquired Resistance to EGFR Inhibitors and Radiation
Shyhmin Huang et al.
CANCER RESEARCH (2013)
PIK3CA Mutation H1047R Is Associated with Response to PI3K/AKT/mTOR Signaling Pathway Inhibitors in Early-Phase Clinical Trials
Filip Janku et al.
CANCER RESEARCH (2013)
Src Family Kinases as Novel Therapeutic Targets to Treat Breast Cancer Brain Metastases
Siyuan Zhang et al.
CANCER RESEARCH (2013)
Co-evolution of breast-to-brain metastasis and neural progenitor cells
Josh Neman et al.
CLINICAL & EXPERIMENTAL METASTASIS (2013)
CNS Metastases in Breast Cancer: Old Challenge, New Frontiers
Nancy U. Lin et al.
CLINICAL CANCER RESEARCH (2013)
Molecular Imaging of Death Receptor 5 Occupancy and Saturation Kinetics In Vivo by Humanized Monoclonal Antibody CS-1008
Ingrid J. G. Burvenich et al.
CLINICAL CANCER RESEARCH (2013)
Carcinoma cells misuse the host tissue damage response to invade the brain
Han-Ning Chuang et al.
GLIA (2013)
ErbB3 downregulation enhances luminal breast tumor response to antiestrogens
Meghan M. Morrison et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
64Cu-DOTA-Trastuzumab PET Imaging in Patients with HER2-Positive Breast Cancer
Kenji Tamura et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
Massively-parallel sequencing assists the diagnosis and guided treatment of cancers of unknown primary
Richard W. Tothill et al.
JOURNAL OF PATHOLOGY (2013)
Reply to 'Intratumoral heterogeneity of HER2 gene amplification in breast cancer: its clinicopathological significance'
Hee Jin Lee et al.
MODERN PATHOLOGY (2013)
Letter to the editor regarding 'Seol H, Lee HJ, Choi Y, et al. Intratumoural heterogeneity of HER2 gene amplification in breast cancer: its clinicopathological significance'
Martin C. Chang
MODERN PATHOLOGY (2013)
Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA study): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 study
Sandra M. Swain et al.
LANCET ONCOLOGY (2013)
MEK162 for patients with advanced melanoma harbouring NRAS or Val600 BRAF mutations: a non-randomised, open-label phase 2 study
Paolo A. Ascierto et al.
LANCET ONCOLOGY (2013)
Selumetinib plus docetaxel for KRAS-mutant advanced non-small-cell lung cancer: a randomised, multicentre, placebo-controlled, phase 2 study
Pasi A. Jaenne et al.
LANCET ONCOLOGY (2013)
Lapatinib plus capecitabine in patients with previously untreated brain metastases from HER2-positive metastatic breast cancer (LANDSCAPE): a single-group phase 2 study
Thomas Bachelot et al.
LANCET ONCOLOGY (2013)
Mutational heterogeneity in cancer and the search for new cancer-associated genes
Michael S. Lawrence et al.
NATURE (2013)
Signatures of mutational processes in human cancer
Ludmil B. Alexandrov et al.
NATURE (2013)
IntOGen-mutations identifies cancer drivers across tumor types
Abel Gonzalez-Perez et al.
NATURE METHODS (2013)
Implementing personalized cancer genomics in clinical trials
Richard Simon et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
Somatic Point Mutation Calling in Low Cellularity Tumors
Karin S. Kassahn et al.
PLOS ONE (2013)
The Small GTPase ARF6 Stimulates β-Catenin Transcriptional Activity During WNT5A-Mediated Melanoma Invasion and Metastasis
Allie H. Grossmann et al.
SCIENCE SIGNALING (2013)
Blocking NRG1 and Other Ligand-Mediated Her4 Signaling Enhances the Magnitude and Duration of the Chemotherapeutic Response of Non-Small Cell Lung Cancer
Ganapati V. Hegde et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Deciphering Signatures of Mutational Processes Operative in Human Cancer
Ludmil B. Alexandrov et al.
CELL REPORTS (2013)
Genomic analysis identifies unique signatures predictive of brain, lung, and liver relapse
J. Chuck Harrell et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
High frequency of complex TP53 mutations in CNS metastases from breast cancer
C. Lo Nigro et al.
BRITISH JOURNAL OF CANCER (2012)
Incidence and time trends of brain metastases admissions among breast cancer patients in Sweden
G. Frisk et al.
BRITISH JOURNAL OF CANCER (2012)
Clinicopathologic Features, Patterns of Recurrence, and Survival Among Women With Triple-Negative Breast Cancer in the National Comprehensive Cancer Network
Nancy U. Lin et al.
CANCER (2012)
Combination of a MEK inhibitor at sub-MTD with a PI3K/mTOR inhibitor significantly suppresses growth of lung adenocarcinoma tumors in KrasG12D-LSL mice
Brett H. Simmons et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2012)
Mutational Processes Molding the Genomes of 21 Breast Cancers
Serena Nik-Zainal et al.
CELL (2012)
A Landscape of Driver Mutations in Melanoma
Eran Hodis et al.
CELL (2012)
Mapping the Hallmarks of Lung Adenocarcinoma with Massively Parallel Sequencing
Marcin Imielinski et al.
CELL (2012)
Whole genome sequencing of matched primary and metastatic acral melanomas
Samra Turajlic et al.
GENOME RESEARCH (2012)
Androgen-independent prostate cancer cells circumvent EGFR inhibition by overexpression of alternative HER receptors and ligands
Dolors Carrion-Salip et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2012)
Intratumoral heterogeneity of HER2 gene amplification in breast cancer: its clinicopathological significance
Hyesil Seol et al.
MODERN PATHOLOGY (2012)
The landscape of cancer genes and mutational processes in breast cancer
Philip J. Stephens et al.
NATURE (2012)
Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes
Andrew V. Biankin et al.
NATURE (2012)
Comprehensive molecular portraits of human breast tumours
Daniel C. Koboldt et al.
NATURE (2012)
Comprehensive genomic characterization of squamous cell lung cancers
Peter S. Hammerman et al.
NATURE (2012)
Neurosurgical management of metastases in the central nervous system
Elizabeth B. Claus
NATURE REVIEWS CLINICAL ONCOLOGY (2012)
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
Marco Gerlinger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
qpure: A Tool to Estimate Tumor Cellularity from Genome-Wide Single-Nucleotide Polymorphism Profiles
Sarah Song et al.
PLOS ONE (2012)
Lapatinib Distribution in HER2 Overexpressing Experimental Brain Metastases of Breast Cancer
Kunal S. Taskar et al.
PHARMACEUTICAL RESEARCH (2012)
Treatment of Brain Metastases: Chemotherapy
Sean A. Grimm
CURRENT ONCOLOGY REPORTS (2012)
Management of Brain Metastasis: Past Lessons, Modern Management, and Future Considerations
Eugene Koay et al.
CURRENT ONCOLOGY REPORTS (2012)
Epidemiology of Brain Metastases
Lakshmi Nayak et al.
CURRENT ONCOLOGY REPORTS (2012)
Burden of breast cancer with brain metastasis: a French national hospital database analysis
L. Benjamin et al.
JOURNAL OF MEDICAL ECONOMICS (2012)
Relevance of PTEN loss in brain metastasis formation in breast cancer patients
Harriet Wikman et al.
BREAST CANCER RESEARCH (2012)
Conversion of epidermal growth factor receptor 2 and hormone receptor expression in breast cancer metastases to the brain
Renata Duchnowska et al.
BREAST CANCER RESEARCH (2012)
Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: a phase 2, multicentre, open-label, non-randomised study
Karen A. Gelmon et al.
LANCET ONCOLOGY (2011)
A framework for variation discovery and genotyping using next-generation DNA sequencing data
Mark A. DePristo et al.
NATURE GENETICS (2011)
Brain metastases as preventive and therapeutic targets
Patricia S. Steeg et al.
NATURE REVIEWS CANCER (2011)
Biodistribution of 89Zr-trastuzumab and PET Imaging of HER2-Positive Lesions in Patients With Metastatic Breast Cancer
E. C. Dijkers et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data
Aaron McKenna et al.
GENOME RESEARCH (2010)
The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline
Mark E. Linskey et al.
JOURNAL OF NEURO-ONCOLOGY (2010)
The brain microenvironment and cancer metastasis
Isaiah J. Fidler et al.
MOLECULES AND CELLS (2010)
Genome remodelling in a basal-like breast cancer metastasis and xenograft
Li Ding et al.
NATURE (2010)
Distant metastasis occurs late during the genetic evolution of pancreatic cancer
Shinichi Yachida et al.
NATURE (2010)
Real-time imaging reveals the single steps of brain metastasis formation
Yvonne Kienast et al.
NATURE MEDICINE (2010)
Resource Utilization in Patients with Brain Metastases Managed with Best Supportive Care, Radiotherapy and/or Surgical Resection: A Markov Analysis
Carsten Nieder et al.
ONCOLOGY (2010)
The role of HER3, the unpretentious member of the HER family, in cancer biology and cancer therapeutics
Dhara N. Amin et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2010)
HER3 and downstream pathways are involved in colonization of brain metastases from breast cancer
Leonard Da Silva et al.
BREAST CANCER RESEARCH (2010)
Pindel: a pattern growth approach to detect break points of large deletions and medium sized insertions from paired-end short reads
Kai Ye et al.
BIOINFORMATICS (2009)
Fast and accurate short read alignment with Burrows-Wheeler transform
Heng Li et al.
BIOINFORMATICS (2009)
HER/ErbB receptor interactions and signaling patterns in human mammary epithelial cells
Yi Zhang et al.
BMC CELL BIOLOGY (2009)
Brain Metastasis: Opportunities in Basic and Translational Research
E. A. Maher et al.
CANCER RESEARCH (2009)
WNT/TCF Signaling through LEF1 and HOXB9 Mediates Lung Adenocarcinoma Metastasis
Don X. Nguyen et al.
CELL (2009)
HER Family Receptor Abnormalities in Lung Cancer Brain Metastases and Corresponding Primary Tumors
Menghong Sun et al.
CLINICAL CANCER RESEARCH (2009)
Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution
Sohrab P. Shah et al.
NATURE (2009)
Genes that mediate breast cancer metastasis to the brain
Paula D. Bos et al.
NATURE (2009)
Genome Alteration Print (GAP): a tool to visualize and mine complex cancer genomic profiles obtained by SNP arrays
Tatiana Popova et al.
GENOME BIOLOGY (2009)
A central role for HER3 in HER2-amplified breast cancer:: implications for targeted therapy
Si Tuen Lee-Hoeflich et al.
CANCER RESEARCH (2008)
HER3 is a determinant for poor prognosis in melanoma
Markus Reschke et al.
CLINICAL CANCER RESEARCH (2008)
Brain metastases: current management and new developments
Riccardo Soffietti et al.
CURRENT OPINION IN ONCOLOGY (2008)
Heregulin-induced activation of ErbB3 by EGFR tyrosine kinase activity promotes tumor growth and metastasis in melanoma cells
Yoko Ueno et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Molecular Origins of Cancer Molecular Basis of Metastasis
Anne C. Chiang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
The neuronal guidance cue Slit2 induces targeted migration and may play a role in brain metastasis of breast cancer cells
Bernd C. Schmid et al.
BREAST CANCER RESEARCH AND TREATMENT (2007)
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer
Antonio C. Wolff et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Basal-like grade III invasive ductal carcinoma of the breast: patterns of metastasis and long-term survival
Laura G. Fulford et al.
BREAST CANCER RESEARCH (2007)
Novel patterns of genome rearrangement and their association with survival in breast cancer
James Hicks et al.
GENOME RESEARCH (2006)
Genomic and transcriptional aberrations linked to breast cancer pathophysiologies
Koei Chin et al.
CANCER CELL (2006)
Identifying breast cancer patients at risk for Central Nervous System (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG)
BC Pestalozzi et al.
ANNALS OF ONCOLOGY (2006)
Brain metastases: epidemiology and pathophysiology
IT Gavrilovic et al.
JOURNAL OF NEURO-ONCOLOGY (2005)
Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the metropolitan Detroit cancer surveillance system
JS Barnholtz-Sloan et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Neuregulin-1 (NRG-1) mRNA and protein in the adult human brain
AJ Law et al.
NEUROSCIENCE (2004)
Share Paper
